CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 632130-632189 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Cohort VI (asymptomatic SAR subjects) received 400 mcg BID.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T84934","span":{"begin":0,"end":59},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T84934","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T22","span":{"begin":0,"end":59},"obj":"Sentence"}],"attributes":[{"subj":"T22","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93eca4","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec939b"}]}]}}